Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Locations now includes Greater London, and the page previously listing 'Greater London Locations' has been removed. The footer item 'HHS Vulnerability Disclosure' has been deleted, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:57:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows a minor revision from v3.3.1 to v3.3.2; no study content or eligibility criteria have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:46:06.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page adds a note that PubMed-sourced publications are auto-filled and may not all pertain to the study, and updates the Revision to v3.3.1. The corresponding deletion text clarifies that PubMed publications are auto-created by ClinicalTrials.gov using the NCT number and may not be related.
    Difference
    0.1%
    Check dated 2025-11-24T14:52:53.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Removed the government funding status notice about NIH operations. This change affects boilerplate site messaging rather than the study details, eligibility criteria, or results.
    Difference
    0.4%
    Check dated 2025-11-17T07:00:23.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    No substantive changes to the study details were observed between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:27.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Core update: add a government funding status notice and update to v3.2.0; remove the old v3.1.0 tag. The new notice provides critical operational status, making it the primary change.
    Difference
    3%
    Check dated 2025-10-05T10:16:30.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.